Skip to main content
. 2019 Jan 21;13(8):1036–1043. doi: 10.1093/ecco-jcc/jjz017

Table 2.

Genetic variants associated with anti-TNF response in patients with IBD and their effect size.

Genetic variants [minor/ major allele] Discovery cohort MAF [NR vs R] Replicate cohort MAF [NR vs R] Combined cohort MAF [NR vs R] OR [95% CI] Adjusted OR [95% CI]
Position Allelic OR [95% CI] Allelic OR [95% CI] Allelic OR [95% CI] [Additive mode]
Candidate gene p-Value p-Value p-Value p-Value p-Value
rs116724455 [C/T] 0.07 vs 0.005 0.06 vs 0.002 0.06 vs 0.003
chr01:173,191,085 13.8 [2.26–85.4] 27.3 [2.42–309] 18.6 [4.38–79.6] 19.9 [4.57–86.7] 43.1 [6.98–266]
TNFSF4, TNFSF18 p = 2.43E-04 p = 6.28E-06 p = 5.37E-08 p = 4.79E-08 p = 1.14E-04
rs2228416 [T/C] 0.11 vs 0.02 0.14 vs 0.03 0.12 vs 0.03
chr09: 19,126,281 5.97 [1.87–19.1] 5.21 [1.76–15.4] 5.33 [2.43–11.7] 5.25 [2.33–11.8] 5.42 [2.05–14.3]
PLIN2,HAUS6 p = 7.17E-04 p = 9.87E-04 p = 3.76E-06 p = 5.24E-06 p = 1.62E-03
rs762787 [T/C] 0.17 vs 0.04 0.19 vs 0.07 0.18 vs 0.06
chr03: 46,488,936 4.74 [1.92–11.7] 3.39 [1.37–8.35] 3.82 [2.03–7.17] 4.27 [2.16–8.48] 5.04 [2.23–11.4]
LTF, CCR5, CCRL2 p = 2.46E-04 p = 5.22E-03 p = 9.51E-06 p = 6.47E-06 p = 1.95E-04
rs9572250 [G/A] 0.45 vs 0.19 0.39 vs 0.21 0.43 vs 0.20
chr13: 70,302,178 3.52 [1.87–6.63] 2.39 [1.18–4.84] 2.94 [1.84–4.70] 3.00 [1.84–4.89] 3.24 [1.80–5.85]
KLHL1 p = 4.30E-05 p = 0.01 p = 2.84E-06 p = 3.19E-06 p = 7.71E-05
rs144256942 [G/A] 0.07 vs 0.003 0.06 vs 0.01 0.06 vs 0.007
chr01: 213,732,082 27.8 [2.83–273] 5.42 [1.01–28.9] 9.30 [2.77–31.2] 9.88 [2.88–33.9] 10.2 [2.26–46.4]
PROX1,RPS6KC1 p = 1.97E-05 p = 0.02 p= 1.27E-05 p = 1.14E-05 p = 4.41E-03
rs523781 [G/C] 0.20 vs 0.06 0.14 vs 0.06 0.17 vs 0.06
chr09: 3.81 [1.65- 2.73 [0.98- 3.36 [1.77- 3.97 4.90 [2.02-
77,323,239 8.80] 7.60] 6.39] [1.95–8.07] 11.9]
RORB,TRPM6 p = 8.84E-04 p = 0.04 p = 9.79E-05 p = 5.28E-05 p = 7.81E-04

Abbreviations: A, adenine; C, cytosine; chr, chromosome; G, guanine; MAF, minor allele frequency; NR, no response; OR, odds ratio; R, response; T, thymine; TNF, tumour necrosis factor; CI, confidence interval,IBD, inflammatory bowel disease.